Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000897069-25-000668
Filing Date
2025-03-20
Accepted
2025-03-20 17:16:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 7630
  Complete submission text file 0000897069-25-000668.txt   9070
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Subject) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92695 | Film No.: 25757778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5102 HARTRIDGE WAY GREENSBORO NC 27407
Business Address
Tracy Thomas Joseph (Filed by) CIK: 0002062715 (see all company filings)

Type: SCHEDULE 13D